Neko Health raises $700M as investors bet on preventative body scanning

Daniel Ek, the Swedish entrepreneur behind Spotify, is placing a major bet on preventative healthcare through his startup Neko Health. The company raised $700 million to build a business centered on body scanning—a technology aimed at catching health issues before they become serious problems.

The funding round underscores investor appetite for a different approach to health: instead of waiting for symptoms, startups are building tools to screen bodies and identify potential risks early. Neko Health is far from alone in this space. Midjourney, known for its AI image generation tool, is building its own body-scanning product. Function Health, a competitor focused on preventative health, has also raised significant capital to expand its offerings. The convergence of money and entrepreneurs around body scanning suggests investors see this as more than a niche market.

The Preventative Health Wave

Why Preventative Care is Gaining Traction

The shift toward preventative screening reflects broader changes in how people think about health management. Rather than treating disease, preventative care aims to identify risk factors and intervene before conditions develop. Neko Health positions body scanning as a way to democratize access to comprehensive health screenings that traditionally required expensive imaging at medical facilities.

The startup’s approach taps into a consumer desire for proactive health management, especially among people who can afford out-of-pocket costs for screening services. As health systems struggle with capacity and preventative care remains underfunded in many cases, private startups see an opening to serve consumers directly.

A Growing Competitive Landscape

Read also: Ex-Tesla Team Raises $12.5M to Automate Supply Chain Decisions · TechCrunch Disrupt 2026 Brings 250 Leaders to San Francisco · Modal Motors strips rare-earth magnets from its motor designs

Multiple Companies Enter Body Scanning

Neko Health is not operating in isolation. Midjourney’s entry into body scanning, even as a secondary project, signals that even generative AI companies see health applications as a natural extension of their capabilities. Function Health’s fundraising and growth indicate sustained investor confidence in the preventative health category.

The Investor Assessment

The fact that multiple well-capitalized startups are moving in this direction simultaneously suggests the market opportunity is significant. Investors like Farooq Abbasi, founder and general partner at Preface Ventures and a backer of Neko Health, are actively assessing how these companies compare and what differentiates them.

Building Scale and Trust

Overcoming Healthcare System Barriers

For body scanning startups to succeed at significant scale, they face fundamental questions about integration with the existing healthcare system. Preventing disease only matters if the information generated leads to actionable medical decisions. That requires not just technology but relationships with physicians, health systems, and insurance companies.

Currently, most of these services operate outside traditional healthcare. They offer screening to consumers directly, with results delivered to the individual rather than integrated into medical records or used by primary care doctors. For the model to shift, body scanning would need to become embedded in standard preventative care workflows and covered or reimbursed by insurance.

The Clinical Validation Question

Another hurdle is clinical validation. Any health screening tool making claims about disease detection or risk prediction eventually faces scrutiny from regulators and the medical community. Startups in this space must demonstrate that their scans actually improve health outcomes, not just identify more signals. That evidence takes time and money to build.

The Path to Healthcare Integration

Multiple levers could accelerate the shift from boutique consumer service to standard healthcare offering. Insurance coverage is one: if insurers begin reimbursing for preventative body scans as part of standard care, adoption could accelerate rapidly. Regulatory approval from health authorities could validate the approach and open doors to integration with medical systems. Partnership deals between startups and hospital networks or primary care clinics could create new pathways for scanning services to reach patients.

The timeline for this shift is uncertain. Preventative healthcare has gained attention for years without fundamentally reshaping how most people access care. Whether body scanning becomes routine or remains an optional service for consumers willing to pay out of pocket will depend on outcomes, costs, and how effectively startups navigate the healthcare system’s complexities.

The Investor Thesis

The $700 million raised by Neko Health reflects confidence that body scanning will become a significant sector within healthcare technology. Investors are essentially betting that preventative screening, when delivered efficiently and at scale, will create economic value and improve health outcomes for enough people to sustain growing companies.

The presence of competitors and capital flowing into the category reinforces that thesis. If only one startup were pursuing body scanning, it might be dismissed as a niche play. Instead, multiple well-funded teams are building variations on the same idea, which suggests investors see a durable market opportunity rather than a transient trend.

Source: TechCrunch